Why SS Innovations (SSII) Is Up 10.8% After Telesurgery Milestone And Auditor Going Concern Doubts

• SS Innovations International, Inc. recently reported that for the fourth quarter of 2025 its revenue rose to US$14.53 million while it recorded a net loss of US$2.47 million, and full-year 2025 revenue increased to US$42.48 million with a reduced net loss of US$12.13 million, although its auditor raised going concern doubts in the latest 10-K.

• Around the same time, the company announced that its SSi Mantra surgical robotic system has been cleared for telesurgeries in Indonesia and the Philippines and has surpassed 150 cumulative telesurgeries, underscoring early traction for its remote surgery technology even as it continues to operate at a loss.

• Next, we'll examine how approval for telesurgeries in Indonesia and the Philippines shapes SS Innovations International's broader investment narrative.

Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

What Is SS Innovations International's Investment Narrative?

To own SS Innovations International, you need to believe that its SSi Mantra platform can carve out a meaningful foothold in surgical robotics and telesurgery, despite persistent losses and a fragile balance sheet. The latest numbers show higher revenue but continued net losses, and the auditor's going concern warning keeps funding and dilution risk firmly in the foreground. The recent telesurgery approvals in Indonesia and the Philippines, along with crossing 150 cumulative telesurgeries, strengthen the near term adoption story and may support the case for further commercial expansion. At the same time, the equity raises, rich price to sales multiple and sharp one year share price decline underline how dependent the thesis is on execution and access to capital. This news helps the catalyst side of the story, but not the risk side.

However, one key financial warning in the latest 10-K is easy to miss. The analysis detailed in our SS Innovations International valuation report hints at an inflated share price compared to its estimated value.

Exploring Other Perspectives

Only one fair value estimate from the Simply Wall St Community sits at US$0.31, showing how thin the current crowd is. Set that against the going concern flag and ongoing losses, and it is clear you are relying on a relatively narrow set of expectations today.

Explore another fair value estimate on SS Innovations International - why the stock might be worth as much as $0.31!

Form Your Own Verdict

Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.